07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
To ensure the protection of the safety and health of employees, the French Supreme Court reiterated ...
Read More >
A few years ago, a major Chinese manufacturer, Fuyao, opened the world’s largest windshield-making ...
Read More >
2019 was a busy year for lawmakers across the nation, underscoring the need for employers to remain ...
Read More >
Private equity (PE) investment in physician groups has steadily grown over the last several years, w...
Read More >
The deadline to comply with Kari’s Law was February 16, 2020. Here’s an overview of what employers...
Read More >
The New York City Commission on Human Rights has issued new enforcement guidance on discrimination b...
Read More >